Skip to content
★ Sign in to follow
TW

Ted William Karkus

Executive
Chief Executive Officer
ProPhase Labs, Inc.
Total declarations
44
Company
1
▲ Purchases (11 ops.)
€1.5M
▼ Sales (4 ops.)
€1.8M

Latest filing published 05 Apr 2023 for ProPhase Labs, Inc..

Filing timeline

BuySale
Ted William Karkus

Insider track record

Disclosed buys
11
Disclosed sells
4
Signal history

Closed purchases

Market purchases
11
Positive at T+90
38%
Median T+90
-2.2%

Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 10 Jun 2021 · 1977 days ago · €142k
    +54.8%
    Entry US$64.00 · Close at T+365 US$99.10
  • Filed 05 Jun 2015 · 4174 days ago · €232k
    -5.8%
    Entry US$13.80 · Close at T+365 US$13.00
  • Filed 19 May 2015 · 4191 days ago · €12k
    -2.2%
    Entry US$13.70 · Close at T+365 US$13.40
  • Filed 17 May 2012 · 5288 days ago · €86k
    +27.7%
    Entry US$11.20 · Close at T+365 US$14.30
  • Filed 18 Nov 2011 · 5469 days ago · €13k
    +14.6%
    Entry US$14.40 · Close at T+365 US$16.50

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Ted William Karkus: trading record in brief

All filings by Ted William Karkus on record concern ProPhase Labs, Inc., in the capacity of chief executive. The record holds 44 filings, for trades running from 21 April 2011 to 5 April 2023.

Market trades split into 11 purchases (€1.5M) and 4 sales (€1.8M). The net balance comes to €277k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 13 share grants and 8 option exercises.

A typical purchase (the median) is worth €109k. Ninety days after publication, 8 purchases show a median change of -2.2%, with the price up in 38% of them. This is a record of the past, not a forecast.

Most recently, on 5 April 2023, the filings show a transaction in ProPhase Labs, Inc. The most recent open-market purchase was published on 10 June 2021, 1,977 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Ted William Karkus

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations44 total

25 of 44 declarations